Optimizing Clinical Outcomes by Optimizing the Management of Hyperlipidemia is organized by C3-Interventional Academy.
Release Date: Oct 23, 2019
Expiration Date: Oct 23, 2020
Ciné-Med assigns this enduring online CME material for a maximum of 1.5 AMA PRA Category 1Credit(s)™. Physicians can acquire credit commensurate based on the extent of their participation in the conference.
At the conclusion of this online CME session, learners should be able to:
• specify the relationship between LDL-C and cardiovascular disease as well as the substantial residual risk among patients receiving statin therapy.
• Discuss PCSK9 inhibition as a unique mechanism to reduce LDL-C and improve cardiovascular outcomes.
• Know the influence of PCSK9 inhibitors on coronary plaque, clinical outcomes, and safety, in particular neurocognitive events.
• Explain recent ACC/AHA guidelines for the management of hyperlipidemia in the context of clinical cases.
Additional details will be posted as soon as information is available.